Freeman Kevin Lee's Form 4 filing
Health Catalyst, Inc. (HCAT) · filed Dec 3, 2024
- Accession no.
- 0001562180-24-008097
- Filed
- Dec 3, 2024
- Trade date
- Dec 1-2, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $67.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Freeman Kevin LeeCIK 0001945797 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2024 | Common Stock | FTax withholdingDisposed | −11,431 | $8.97 | −$102,536.07 | 244,450 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −7,500 | $8.94 | −$67,050 | 236,950 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.